Developer docs
API playgroundTry for free, no card

Search company profiles

Ulrich

Full company profile

uuid000cz7x

Namestring
Ulrich
Legal namestring
ulrich GmbH & Co. KG
Company typeenum
Private
Founded yearint
1912
Descriptiontext

ulrich medical, legally ulrich GmbH & Co. KG, is a privately held German medical device manufacturer founded in 1912 and headquartered in Ulm, Germany. The company operates two business divisions under a single roof: radiology, focused on contrast media injectors for CT, MRI, and mammography; and spinal surgery, covering rod-screw systems, vertebral body replacements, cages, plates, and synthetic bone substitutes. All development and manufacturing are conducted at the Ulm site, which the company markets under a 'Made in Germany' quality positioning. Revenue reached EUR 178 million in FY2025, up 10% year-over-year and ahead of the industry average, on a headcount of 501-1,000.

The core technology portfolio centers on syringe-less contrast media injectors, led by the CT motion platform and its successor CT Motion Injector system with the CDadapt automated density function, SYNCopen RIS/PACS integration software, and the Contrast Booster respiratory gating accessory for pulmonary CT. The CT Motion Injector's cleared configuration extends disposable usability to 24 hours (from 8), supports up to 36 contrast media bottles per pump tubing, and adds broadened pharmaceutical compatibility including Bracco Diagnostics' Iohexol IBP. In spinal surgery, the portfolio spans uCentum and uBase thoracolumbosacral screw-rod systems with modular MIS options, neon³ for occipitocervical fixation, cosmicMIA for dynamic stabilization, the obelisc continuously expandable vertebral body replacement, and the newly launched Artus cervical plate system. Production capacity was materially expanded in May 2025 with the opening of Plant III, a dedicated contrast media injector facility.

ulrich medical monetizes through direct B2B hardware sales of medical devices to hospitals, radiology departments, and spinal surgery centers, supplemented by channel partnerships including a November 2023 private-label agreement with Bracco Imaging S.p.A. for U.S. distribution of syringeless MRI contrast injectors. Pricing is quote-based and not publicly disclosed. The company sells directly in DACH, Europe, and the United States (via subsidiary ulrich medical USA), and reaches APAC markets including Singapore. Marketing leverages global clinical congresses (RSNA, EUROSPINE, AOCR, World Spine, JFR Paris), the ulrich medical Academy training platform, and a dedicated knowledge base. The company is family-controlled with Christoph Ulrich as Managing Partner and is led by a management board comprising Friedrich von Rechteren (CEO and Chairman, since June 2025) and Gordon Bittig (appointed January 2026).

Short descriptiontext

ulrich medical is a privately held German medical device manufacturer founded in 1912, developing and producing contrast media injectors for radiology and spinal implant systems for orthopedic surgeons, serving hospitals and surgical centers globally from its Ulm headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNeu-ulm, Germany
HQ citystring
Neu-ulm
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contrast media injectors, spinal implant systems, medical device manufacturing, radiology diagnostic equipment, spinal surgery instruments
Industry2 codes
1Contrast Media Injectors & Radiology Accessories
CodeHLAHABAKPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Devices - Diagnostic Imaging and Spinal Implants
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Hardware Sales
TypeHardware Sales
Description

ulrich medical generates revenue through the sale of medical technology hardware including contrast media injectors for CT and MRI imaging, and spinal surgery products including rod-screw systems, vertebral body replacements, cages, plates, and bone substitute materials. Products are developed, manufactured, and sold under one roof in Germany, supporting the 'Made in Germany' quality positioning.

ulrichmedical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 15 records shown
1CT motion
Description

Syringe-less contrast media injector for CT diagnostic imaging with three media connection points

ulrichmedical.com
+14 more records
Core offering1 text field

Ulrich GmbH & Co. KG develops, manufactures, and sells medical devices in two segments: Radiology (contrast media injectors for CT and MRI imaging, including syringe-less systems with software integration) and Spinal Surgery (rod-screw systems, vertebral body replacements, cages, plates, and bone substitutes). All products are designed, manufactured, and sold at the company's Ulm, Germany headquarters under the 'Made in Germany' quality positioning, generating approximately EUR 178 million in annual revenue.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Revenue grew 10% to EUR 178 million in 2025, outpacing industry average
+3 more records
Product overview1 text field

ulrich medical develops, manufactures, and sells medical technology products in Germany under the 'Made in Germany' label. The company operates in two main divisions: Radiology and Spinal Surgery. The Radiology division produces contrast media injectors including CT motion™ and CT motion™ SPICY for CT imaging, and Max 3™ and Max 2M™ for MRI imaging, along with accessories like the Contrast Booster™ breathing control device and supporting software features (RIS/PACS Interface, SYNCopen™, CDadapt). The Spinal Surgery division offers a comprehensive portfolio including rod-screw systems (neon³™, cosmicMIA™, uCentum™, uBase™), vertebral body replacements (ADD™, ADDplus™, obelisc™), cages (cerv-X™, pezo™, tezo™), bone substitutes (uDesis™), and plate systems (Origin™, Artus™). The company generates approximately EUR 178 million in annual revenue.

Product and service20 records
1CT motion™
CategoryContrast Media Injector
Description

Contrast media injector for CT imaging with three media connection points, designed for diagnostic imaging procedures in hospitals and radiology departments.

2CT motion™ SPICY
CategoryContrast Media Injector
Description

Contrast media injector for CT with expanded features beyond the standard CT motion, enhanced for diagnostic imaging procedures.

3Contrast Booster™
CategoryRadiology Accessory
Description

Breathing control device to improve the quality of pulmonary CT imaging examinations through respiratory gating technology.

4Max 3™
CategoryContrast Media Injector
Description

Contrast media injector for MRI with three media connection points for diagnostic imaging procedures.

5Max 2M™
CategoryContrast Media Injector
Description

Contrast media injector for MRI with two media connection points for diagnostic imaging procedures.

6neon³™
CategorySpinal Implant - Rod-Screw System
Description

Occipitocervical screw-rod system for spinal surgery procedures, used in posterior cervical fusion.

7cosmicMIA™
CategorySpinal Implant - Rod-Screw System
Description

Dynamic screw-rod system for spinal stabilization allowing controlled movement while providing support.

8uCentum™
CategorySpinal Implant - Rod-Screw System
Description

Thoracolumbosacral screw-rod system for spinal fusion procedures, with modular implant and instrument options including MIS (minimally invasive surgery) configurations.

9uBase™
CategorySpinal Implant - Rod-Screw System
Description

Polyaxial screw system for spinal surgery, used in thoracolumbar fusion procedures.

10obelisc™
CategorySpinal Implant - Vertebral Body Replacement
Description

Continuously expandable vertebral body replacement implant for spinal reconstruction procedures, including corpectomy.

11ADD™
CategorySpinal Implant - Vertebral Body Replacement
Description

Vertebral body replacement system for spinal surgery procedures.

12ADDplus™
CategorySpinal Implant - Vertebral Body Replacement
Description

Enhanced vertebral body replacement system for spinal surgery procedures.

13Artus™
CategorySpinal Implant - Plate System
Description

Cervical plate system for surgical procedures on the cervical and cervicothoracic spine.

14Origin™
CategorySpinal Implant - Plate System
Description

Plate system for spinal surgery procedures, used in anterior cervical fusion.

15cerv-X™
CategorySpinal Implant - Cage
Description

Cervical cage implant for spinal surgery procedures, used in anterior cervical fusion.

16pezo™
CategorySpinal Implant - Cage
Description

Cage implant for spinal surgery procedures, used in thoracolumbar fusion.

17tezo™
CategorySpinal Implant - Cage
Description

Cage implant for spinal surgery procedures, used in thoracolumbar fusion.

18uDesis™
CategoryBone Substitute
Description

Synthetic bone substitute for spinal surgery applications.

19V-Steady
CategoryBone Cement
Description

Bone cement for spinal surgery applications.

20Heating Cabinet
CategoryRadiology Accessory
Description

Heating cabinet for contrast media and radiology department use.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-01
Description

Italy-based Bracco Imaging S.p.A. partnered with Germany's Ulrich GmbH & Co. KG in November 2023 to launch a syringeless MRI contrast injector in the U.S. market through a private-label agreement. Under this arrangement, Bracco distributes the ulrich medical syringeless MRI injector under their own branding, leveraging Bracco's established contrast media portfolio and US distribution network. This partnership combines Bracco's contrast agent expertise and market presence with ulrich medical's injector technology.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major imaging equipment vendor that also sells contrast media injectors compatible with its CT and MRI systems. Indirect but significant competitor to ulrich in the radiology injector category, often bundled with system sales.

TypeBroad incumbent
Description

Major diversified orthopedic and spine player with a broad spinal hardware portfolio. Comparable to ulrich on the spinal surgery side and a meaningful competitor for hospital contract share, though materially larger and broader.

TypeDirect peer
Description

Spine-focused company with rod-screw systems, interbody devices, and enabling technology offerings that overlap directly with ulrich's uCentum, uBase, and vertebral body replacement lines. Closest pure-play spine peer in size and product scope.

TypeBroad incumbent
Description

Largest diversified medical device company with a leading spine surgery portfolio covering rod-screw systems, interbody devices, and enabling technologies. Far larger and broader, but the dominant competitor in ulrich's spinal surgery division.

TypeDirect peer
Description

Mid-sized spine and orthopedic device company with rod-screw systems, cervical plating, and bone growth stimulation products. Comparable in scale and product portfolio scope to ulrich's spinal surgery division.

TypeDirect peer
Description

Pure-play spine surgery specialist offering comprehensive implant systems across cervical, thoracolumbar, and vertebral body replacement categories. Most directly comparable spine-focused peer to ulrich's spinal surgery division by product mix.

TypeDirect peer
Description

French-headquartered specialty contrast media and injector company with a similar mid-sized profile to ulrich. Competes directly in CT and MRI contrast injection and is the closest size-matched public peer in the radiology division.

TypeDirect peer
Description

Italian-headquartered contrast media producer that has its own EmpowerCTA injector line and is also ulrich medical's US private-label distribution partner for the syringeless MRI contrast injector. Directly comparable product portfolio (injectors + contrast media) and dual competitor/channel-partner relationship make it the closest peer.

TypeBroad incumbent
Description

Through its Medrad radiology business, Bayer is the market leader in contrast media injectors globally and a direct competitor to ulrich's CT motion and Max injector lines. Far larger and broader portfolio, but the most direct comparable in the core injector category.

TypeDirect peer
Description

German family-owned medical technology company with a sizable spinal surgery and orthopedic implants franchise under its Aesculap division. Strong peer match on country of origin, ownership profile, and spinal implant product overlap with ulrich.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ulrich

Medical Devices - Diagnostic Imaging and Spinal Implantsulrichmedical.com

ulrich medical is a privately held German medical device manufacturer founded in 1912, developing and producing contrast media injectors for radiology and spinal implant systems for orthopedic surgeons, serving hospitals and surgical centers globally from its Ulm headquarters.

What Ulrich does

ulrich medical, legally ulrich GmbH & Co. KG, is a privately held German medical device manufacturer founded in 1912 and headquartered in Ulm, Germany. The company operates two business divisions under a single roof: radiology, focused on contrast media injectors for CT, MRI, and mammography; and spinal surgery, covering rod-screw systems, vertebral body replacements, cages, plates, and synthetic bone substitutes. All development and manufacturing are conducted at the Ulm site, which the company markets under a 'Made in Germany' quality positioning. Revenue reached EUR 178 million in FY2025, up 10% year-over-year and ahead of the industry average, on a headcount of 501-1,000.

The core technology portfolio centers on syringe-less contrast media injectors, led by the CT motion platform and its successor CT Motion Injector system with the CDadapt automated density function, SYNCopen RIS/PACS integration software, and the Contrast Booster respiratory gating accessory for pulmonary CT. The CT Motion Injector's cleared configuration extends disposable usability to 24 hours (from 8), supports up to 36 contrast media bottles per pump tubing, and adds broadened pharmaceutical compatibility including Bracco Diagnostics' Iohexol IBP. In spinal surgery, the portfolio spans uCentum and uBase thoracolumbosacral screw-rod systems with modular MIS options, neon³ for occipitocervical fixation, cosmicMIA for dynamic stabilization, the obelisc continuously expandable vertebral body replacement, and the newly launched Artus cervical plate system. Production capacity was materially expanded in May 2025 with the opening of Plant III, a dedicated contrast media injector facility.

ulrich medical monetizes through direct B2B hardware sales of medical devices to hospitals, radiology departments, and spinal surgery centers, supplemented by channel partnerships including a November 2023 private-label agreement with Bracco Imaging S.p.A. for U.S. distribution of syringeless MRI contrast injectors. Pricing is quote-based and not publicly disclosed. The company sells directly in DACH, Europe, and the United States (via subsidiary ulrich medical USA), and reaches APAC markets including Singapore. Marketing leverages global clinical congresses (RSNA, EUROSPINE, AOCR, World Spine, JFR Paris), the ulrich medical Academy training platform, and a dedicated knowledge base. The company is family-controlled with Christoph Ulrich as Managing Partner and is led by a management board comprising Friedrich von Rechteren (CEO and Chairman, since June 2025) and Gordon Bittig (appointed January 2026).

Ulrich firmographics

Firmographics
Name
Ulrich
Legal name
ulrich GmbH & Co. KG
Website
https://ulrichmedical.com
Company type
Private
Founded year
1912
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ulrich medical is a privately held German medical device manufacturer founded in 1912, developing and producing contrast media injectors for radiology and spinal implant systems for orthopedic surgeons, serving hospitals and surgical centers globally from its Ulm headquarters.
Ownership category
akta.pro rank

Ulrich industry classification

Industry
Product category
Medical Devices - Diagnostic Imaging and Spinal Implants
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Contrast Media Injectors & Radiology Accessories (HLAHABAK)
akta.pro secondary industry
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL)

Keywords

  • Contrast media injectors
  • Spinal implant systems
  • Medical device manufacturing
  • Radiology diagnostic equipment
  • Spinal surgery instruments

Where Ulrich is headquartered

Location

Headquarters

HQ city
Neu-ulm
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Ulrich business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Device Hardware Sales: ulrich medical generates revenue through the sale of medical technology hardware including contrast media injectors for CT and MRI imaging, and spinal surgery products including rod-screw systems, vertebral body replacements, cages, plates, and bone substitute materials. Products are developed, manufactured, and sold under one roof in Germany, supporting the 'Made in Germany' quality positioning.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Ulrich product offering

Product offering

Core offering

Ulrich GmbH & Co. KG develops, manufactures, and sells medical devices in two segments: Radiology (contrast media injectors for CT and MRI imaging, including syringe-less systems with software integration) and Spinal Surgery (rod-screw systems, vertebral body replacements, cages, plates, and bone substitutes). All products are designed, manufactured, and sold at the company's Ulm, Germany headquarters under the 'Made in Germany' quality positioning, generating approximately EUR 178 million in annual revenue.

Product overview

ulrich medical develops, manufactures, and sells medical technology products in Germany under the 'Made in Germany' label. The company operates in two main divisions: Radiology and Spinal Surgery. The Radiology division produces contrast media injectors including CT motion™ and CT motion™ SPICY for CT imaging, and Max 3™ and Max 2M™ for MRI imaging, along with accessories like the Contrast Booster™ breathing control device and supporting software features (RIS/PACS Interface, SYNCopen™, CDadapt). The Spinal Surgery division offers a comprehensive portfolio including rod-screw systems (neon³™, cosmicMIA™, uCentum™, uBase™), vertebral body replacements (ADD™, ADDplus™, obelisc™), cages (cerv-X™, pezo™, tezo™), bone substitutes (uDesis™), and plate systems (Origin™, Artus™). The company generates approximately EUR 178 million in annual revenue.

Differentiator

Problem solved

Functional benefit

Brands

  • CT motion: Syringe-less contrast media injector for CT diagnostic imaging with three media connection points
  • CT motion SPICY
  • Contrast Booster
  • Max 3
  • Max 2M
  • neon3
  • cosmicMIA
  • uCentum
  • uBase
  • obelisc
  • ADD
  • ADDplus
  • Artus
  • uDesis
  • Academy

Products and services

  • CT motion™ Contrast media injector for CT imaging with three media connection points, designed for diagnostic imaging procedures in hospitals and radiology departments.
  • CT motion™ SPICY Contrast media injector for CT with expanded features beyond the standard CT motion, enhanced for diagnostic imaging procedures.
  • Contrast Booster™ Breathing control device to improve the quality of pulmonary CT imaging examinations through respiratory gating technology.
  • Max 3™ Contrast media injector for MRI with three media connection points for diagnostic imaging procedures.
  • Max 2M™ Contrast media injector for MRI with two media connection points for diagnostic imaging procedures.
  • neon³™ Occipitocervical screw-rod system for spinal surgery procedures, used in posterior cervical fusion.
  • cosmicMIA™ Dynamic screw-rod system for spinal stabilization allowing controlled movement while providing support.
  • uCentum™ Thoracolumbosacral screw-rod system for spinal fusion procedures, with modular implant and instrument options including MIS (minimally invasive surgery) configurations.
  • uBase™ Polyaxial screw system for spinal surgery, used in thoracolumbar fusion procedures.
  • obelisc™ Continuously expandable vertebral body replacement implant for spinal reconstruction procedures, including corpectomy.
  • ADD™ Vertebral body replacement system for spinal surgery procedures.
  • ADDplus™ Enhanced vertebral body replacement system for spinal surgery procedures.
  • Artus™ Cervical plate system for surgical procedures on the cervical and cervicothoracic spine.
  • Origin™ Plate system for spinal surgery procedures, used in anterior cervical fusion.
  • cerv-X™ Cervical cage implant for spinal surgery procedures, used in anterior cervical fusion.
  • pezo™ Cage implant for spinal surgery procedures, used in thoracolumbar fusion.
  • tezo™ Cage implant for spinal surgery procedures, used in thoracolumbar fusion.
  • uDesis™ Synthetic bone substitute for spinal surgery applications.
  • V-Steady Bone cement for spinal surgery applications.
  • Heating Cabinet Heating cabinet for contrast media and radiology department use.

Quantifiable outcome

  • Revenue grew 10% to EUR 178 million in 2025, outpacing industry average
  • +3 more outcomes

Companies that use Ulrich

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Ulrich technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature9 records

Ulrich partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Bracco Imaging S.p.A.coreChannel Partner/ Reseller/ Distributor · 1 November 2023Italy-based Bracco Imaging S.p.A. partnered with Germany's Ulrich GmbH & Co. KG in November 2023 to launch a syringeless MRI contrast injector in the U.S. market through a private-label agreement. Under this arrangement, Bracco distributes the ulrich medical syringeless MRI injector under their own branding, leveraging Bracco's established contrast media portfolio and US distribution network. This partnership combines Bracco's contrast agent expertise and market presence with ulrich medical's injector technology.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Ulrich competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare Technologies Inc. Major imaging equipment vendor that also sells contrast media injectors compatible with its CT and MRI systems. Indirect but significant competitor to ulrich in the radiology injector category, often bundled with system sales.
  • Stryker Corporation: Major diversified orthopedic and spine player with a broad spinal hardware portfolio. Comparable to ulrich on the spinal surgery side and a meaningful competitor for hospital contract share, though materially larger and broader.
  • Medtronic plc: Largest diversified medical device company with a leading spine surgery portfolio covering rod-screw systems, interbody devices, and enabling technologies. Far larger and broader, but the dominant competitor in ulrich's spinal surgery division.
  • Bayer AG (Radiology / Medrad): Through its Medrad radiology business, Bayer is the market leader in contrast media injectors globally and a direct competitor to ulrich's CT motion and Max injector lines. Far larger and broader portfolio, but the most direct comparable in the core injector category.

Direct peers

  • NuVasive (a Globus Medical company): Spine-focused company with rod-screw systems, interbody devices, and enabling technology offerings that overlap directly with ulrich's uCentum, uBase, and vertebral body replacement lines. Closest pure-play spine peer in size and product scope.
  • Orthofix Medical Inc. Mid-sized spine and orthopedic device company with rod-screw systems, cervical plating, and bone growth stimulation products. Comparable in scale and product portfolio scope to ulrich's spinal surgery division.
  • Globus Medical: Pure-play spine surgery specialist offering comprehensive implant systems across cervical, thoracolumbar, and vertebral body replacement categories. Most directly comparable spine-focused peer to ulrich's spinal surgery division by product mix.
  • Guerbet Group: French-headquartered specialty contrast media and injector company with a similar mid-sized profile to ulrich. Competes directly in CT and MRI contrast injection and is the closest size-matched public peer in the radiology division.
  • Bracco Imaging S.p.A. Italian-headquartered contrast media producer that has its own EmpowerCTA injector line and is also ulrich medical's US private-label distribution partner for the syringeless MRI contrast injector. Directly comparable product portfolio (injectors + contrast media) and dual competitor/channel-partner relationship make it the closest peer.
  • B. Braun SE (Aesculap division): German family-owned medical technology company with a sizable spinal surgery and orthopedic implants franchise under its Aesculap division. Strong peer match on country of origin, ownership profile, and spinal implant product overlap with ulrich.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

Ulrich social profiles

Digital presence

Ulrich financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ulrich leadership team

Management profile

Number of profiles

Profiles3 records

Ulrich subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Ulrich funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ulrich M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ulrich

What does Ulrich do?

Ulrich GmbH & Co. KG develops, manufactures, and sells medical devices in two segments: Radiology (contrast media injectors for CT and MRI imaging, including syringe-less systems with software integration) and Spinal Surgery (rod-screw systems, vertebral body replacements, cages, plates, and bone substitutes). All products are designed, manufactured, and sold at the company's Ulm, Germany headquarters under the 'Made in Germany' quality positioning, generating approximately EUR 178 million in annual revenue.

Is Ulrich a public or private company?

Ulrich is a private company. It is classified as family owned and is currently operating.

When was Ulrich founded?

Ulrich was founded in 1912. It employs 501 to 1,000 people.

Where is Ulrich based?

Ulrich is headquartered in Neu-ulm, Germany, in the Europe region.

How does Ulrich make money?

One revenue line is on record: medical Device Hardware Sales.

Who are Ulrich's main competitors?

Broad incumbents on record are GE HealthCare Technologies Inc., Stryker Corporation, Medtronic plc and Bayer AG (Radiology / Medrad). Direct peers are NuVasive (a Globus Medical company), Orthofix Medical Inc., Globus Medical, Guerbet Group, Bracco Imaging S.p.A. and B. Braun SE (Aesculap division).

Does Ulrich have an API?

No public API is recorded for Ulrich.

What industry is Ulrich in?

Ulrich's product category is Medical Devices - Diagnostic Imaging and Spinal Implants. Its primary akta.pro industry code is HLAHABAK, Contrast Media Injectors & Radiology Accessories, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogUlrich Medical Selects ValGenesis iVal™ for SAP-Driven CSV UpgradeUlrich Medical selected ValGenesis iVal to modernize computer system validation for its SAP rollout. The Germany-based medical device company will replace manual validation with a digital approach, starting at headquarters with plans for global expansion. The AI-enabled platform centralizes validation planning, test authoring, and execution.openPR.comGlobal Drivers Analysis: The Rapid Evolution of the Contrast Injection Lines MarketThe global contrast injection lines market is projected to reach $5.45 billion by 2030, growing at a compound annual growth rate of 6.7%, driven by increasing demand for minimally invasive imaging techniques, integration of artificial intelligence in imaging workflows, and expansion of outpatient diagnostic centers. In November 2023, Bracco Imaging S.p.A. partnered with Ulrich Medical GmbH & Co. KG to enhance its contrast media delivery capabilities, and in May 2025, Bracco Diagnostics Inc. launched the Max 3 syringeless injector system for MRI environments, featuring wireless operation and contamination prevention technology.openPR.comEmerging Growth Trends Driving Expansion in the Contrast Media Injectors MarketThe contrast media injectors market is projected to reach $2.73 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.1%, driven by investments in imaging infrastructure, adoption of minimally invasive diagnostic techniques, and workflow automation. In November 2023, Italy-based Bracco Imaging S.p.A. partnered with Germany's Ulrich GmbH & Co. KG to launch a syringeless MRI contrast injector in the U.S. market through a private-label agreement. Additionally, Germany-based Fresenius Kabi introduced two drugs in the U.S. in August 2023—Gadobutrol Injection and Plerixafor Injection—expanding its radiology and oncology portfolios.openPR.comGlobal Contrast Media Injectors Market Expands with U.S. Leadership and China Acceleration, as GE Healthcare, Bayer AG, Bracco Imaging, and Ulrich Drive Innovation-Led GrowthFuture Market Insights projects the global Contrast Media Injectors Market will grow from USD 5.2 billion in 2025 to USD 9.3 billion by 2035, representing a 6.0% CAGR over the decade. Growth is driven by rising chronic disease prevalence, technological advancements including AI-enabled injectors and automation, and expanding healthcare infrastructure in emerging markets, with hospitals accounting for 55% of end-use and consumables representing the leading product segment at 50% share. India is projected to record the highest country-level growth at 10% CAGR, followed by China at 8.2%, while the market remains moderately consolidated with Tier 1 players holding 15-20% share.The Florida Times-UnionMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, Inc. announced that its client ulrich medical has received its fourth FDA clearance for the CT Motion Injector System, a next-generation syringe-less injector for diagnostic imaging, marking over a decade of regulatory collaboration between the two firms. The cleared system introduces significant advancements including extended disposable usability of up to 24 hours, expanded pharmaceutical capacity supporting up to 36 contrast media bottles per pump tubing, and a new automated contrast medium density function. ulrich medical, headquartered in Germany, has expanded its U.S. market share since its first FDA submission in 2017, growing beyond the FDA's small business designation.The Topeka Capital-JournalMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense, a regulatory and quality consulting firm, announced that its client ulrich medical has received its fourth FDA clearance for the CT Motion Injector, a next-generation syringe-less CT injector system designed for diagnostic imaging. The cleared device nearly doubles efficiency over prior models, with extended disposable usability of up to 24 hours, support for up to 36 contrast media bottles per pump tubing, and a new automated software function called CDadapt that autonomously adjusts contrast media density. The milestone marks more than a decade of collaboration between the two companies since 2012, during which ulrich medical expanded its U.S. market share and product portfolio.TodaysmedicaldevelopmentsSyringe-less injector system for diagnostic imaging obtains fourth FDA clearanceMethodSense, Inc. announced that its client ulrich medical received its fourth FDA clearance for the ulrich medical CT Motion Injector, a next-generation syringe-less injector system used in diagnostic imaging, representing another milestone in their more than decade-long partnership. The newly cleared system introduces several advancements including extended disposable usability (up to 24 hours versus the previous 8 hours), expanded pharmaceutical capacity supporting up to 36 contrast media bottles per pump tubing (nearly doubling throughput), and an automated contrast medium density function called CDadapt, which together nearly double the efficiency of prior models. Ulrich medical has expanded its U.S. market share and product portfolio since its first FDA submission in 2017, growing beyond the FDA's small business designation.York Daily RecordMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense supported ulrich medical in obtaining its fourth FDA clearance for the CT Motion Injector, a syringe-less system used in diagnostic imaging. The clearance highlights improvements in safety, efficiency, and compatibility, and reflects a long-standing partnership that began in 2012.Chillicothe GazetteMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense announced that its client ulrich medical received its fourth FDA clearance for the CT Motion Injector, a next-generation syringe-less injector system for computed tomography diagnostic imaging. The newly cleared system nearly doubles efficiency of prior models with features including 24-hour extended disposable usability, support for up to 36 contrast media bottles per pump tubing, and an automated contrast media density adjustment function called CDadapt. The clearance consolidates a collaboration spanning since 2012 and marks ulrich medical's expanded U.S. market presence beyond its initial FDA small business designation.The Journal StandardMethodSense Supports ulrich medical to Fourth FDA Clearance for Innovative Computed Tomography (CT) Injector SystemMethodSense announced that its client ulrich medical received its fourth FDA clearance for the CT Motion Injector, a next-generation syringe-less CT injector system for diagnostic imaging. The newly cleared system introduces key advancements including extended disposable usability (up to 24 hours), expanded pharmaceutical capacity (up to 36 contrast media bottles per pump tubing), and automated contrast medium density adjustment through CDadapt software. The collaboration between the two companies spans over a decade since 2012, with ulrich medical having expanded its U.S. market share and product portfolio since its first FDA submission in 2017.